MYGN

Myriad Genetics Inc.

1 day chart

About MYGN

Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company provides testing that helps assess an individual’s risk for developing disease or disease progression and guides treatment decisions across medical specialties where genetic insights can significantly improve patient health care and lower health care costs, and includes corporate services, such as finance, human resources, legal and information technology. It has three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test which can reveal a baby's gender as early as six weeks into pregnancy. Its products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, and EndoPredict, Foresight, Prequel, and SneakPeek and GeneSight.

Buy US stocks in Australia starting with MYGN. Open an account and start investing today!

Market Capitalisation

$1.70B

Price-earnings ratio

Dividend yield

0.00%

Volume

571.73K

High today

$19.29

Low today

$18.61

Open price

$19.16

52-week high

$24.21

52-week low

$13.82

MYGN FAQs

Can I buy MYGN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy MYGN shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Myriad Genetics Inc.?

One share of Myriad Genetics Inc. is valued at $19.20.

What is the ticker symbol for Myriad Genetics Inc.?

The ticker symbol for Myriad Genetics Inc. is MYGN.

How do I buy MYGN shares in Australia?

To buy MYGN stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in MYGN

What is the 52-week high for Myriad Genetics Inc. stock?

The Myriad Genetics Inc. 52-week high stock price is $24.21.

What is the 52-week low for Myriad Genetics Inc. stock?

The Myriad Genetics Inc. 52-week low stock price is $13.82.

What is the market capitalisation of Myriad Genetics Inc. MYGN?

As of 03/12/2023 Myriad Genetics Inc. has a market cap of $1.7B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.